Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients

Nutrition Research

Volumn 32, Issue 6, 2012, Pages 421-427

  Bogdanski, Pawel ^a   Suliburska, Joanna ^b   Szulinska, Monika ^a   Stepien, Marta ^a   Pupek Musialik, Danuta ^a   Jablecka, Anna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Green tea; Hypertension; Inflammation; Insulin resistance; Obesity; Oxidative stress; Polyphenol epigallocatechin 3 gallate; Randomized trial

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; GREEN TEA EXTRACT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SARTAN DERIVATIVE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTHROPOMETRY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTPATIENT DEPARTMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; PLANT EXTRACTS; TEA; TRIGLYCERIDES;

EID: 84863103768     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2012.05.007     Document Type: Article

References (47)

1. Kurukulasuriya L., Stas S., Lastra G., Manrique C., Sowers J. Hypertension in obesity. Endocrinol Metab Clin North Am 2008, 37:647-662.
2. Mehta S., Farmer J. Obesity and inflammation: a new look at an old problem. Curr Atheroscler Rep 2007, 9:134-138.
3. Valdecantos M., Pérez-Matute P., Martínez J. Obesity and oxidative stress: role of antioxidant supplementation. Rev Invest Clin 2009, 61:127-139.
4. Harrison D.G., Guzik T., Lob H., Madhur M., Marvar P., Thabet S., et al. Inflammation, immunity, and hypertension. Hypertension 2011, 57:132-140.
5. Sarafidis P., Grekas D. Insulin resistance and oxidant stress: an interrelation with deleterious renal consequences?. J Cardiometab Syndr 2007, 2:139-142.
6. Manabe I. Inflammatory process in atherosclerosis. Nihon Rinsho 2011, 69:13-17.
7. Dona M., Dell'Aica I., Calabrese F., Benelli R., Morini M., Albini A., et al. Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J Immunol 2003, 170:4335-4341.
8. Ahmed S., Wang N., Lalonde M., Goldberg V.M., Haqqi T.M. Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1 beta-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes. J Pharmacol Exp Ther 2004, 308:767-773.
9. Sudano Roccaro A., Blanco A.R., Giuliano F., Rusciano D., Enea V. Epigallocatechin-gallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells. Antimicrob Agents Chemother 2004, 48:1968-1973.
10. Oak M.H., El Bedoui J., Schini-Kerth V.B. Antiangiogenic properties of natural polyphenols from red wine and green tea. J Nutr Biochem 2005, 16:1-8.
11. Juśkiewicz J., Zduńczyk Z., Jurgoński A., Brzuzan Ł., Godycka-Kłos I., Zary-Sikorska E. Extract of green tea leaves partially attenuates streptozotocin-induced changes in antioxidant status and gastrointestinal functioning in rats. Nutr Res 2008, 28:343-349.
12. Almajano M.P., Vila I., Gines S. Neuroprotective effects of white tea against oxidative stress-induced toxicity in striatal cells. Neurotox Res 2011, 20(4):372-378.
13. Kuriyama S., Shimazu T., Ohmori K., Kikuchi N., Nakaya N., Nishino Y., et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 2006, 296:1255-1265.
14. Sasazuki S., Kodama H., Yoshimasu K., Liu Y., Washio M., Tanaka K., et al. Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol 2000, 10:401-408.
15. Brown A.L., Lane J., Holyoak C., Nicol B., Mayes A.E., Dadd T. Health effects of green tea catechins in overweight and obese men: a randomised controlled cross-over trial. Br J Nutr 2011, 106:1880-1889.
16. Oyama J., Maeda T., Sasaki M., Kozuma K., Ochiai R., Tokimitsu I., et al. Green tea catechins improve human forearm vascular function and have potent anti-inflammatory and anti-apoptotic effects in smokers. Intern Med 2010, 49:2553-2559.
17. Jin Y., Im J., Park E., Cho M., Han X., Lee J., et al. Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity. J Cardiovasc Pharmacol 2008, 51:45-54.
18. Van Aller G., Carson J., Tang W., Peng H., Zhao L., Copeland R., et al. Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor. Biochem Biophys Res Commun 2011, 406:194-199.
19. WHO Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995, 854:1-452.
20. Mancia G., Laurent S., Agabiti-Rosei E., Ambrosioni E., Burnier M., Caulfield M.J., et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009, 27:2121-2158.
21. Temple R., Clark P.M., Hales C.N. Measurement of insulin secretion in type 2 diabetes: problems and pitfalls. Diabet Med 1992, 9:503-512.
22. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta cell function from fasting glucose and insulin concentration in man. Diabetologia 1985, 28:412-419.
23. Ledue T.B., Weiner D.L., Sipe J.D., Poulin S.E., Collins M.F., Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem 1998, 35:745-753.
24. R&D System Europe: Quantikine®. Human TNF-α immunoassay. For the quantitative determination of human tumor necrosis factor alpha (TNF-alpha) concentrations in cell culture supernates, serum, and plasma. Web site 2011. http://www.mdsysems/com/pdf/dta00c.pdf.
25. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004, 37:277-285.
26. Clinical and Laboratory Standards Institute/NCCLS. Procedures for the Handling and Processing of Blood Specimens; Approved Guideline. Third Edition. 2004.
27. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative centrifuge. Clin Chem 1972, 18:499-502.
28. Brown A.L., Lane J., Coverly J., Stocks J., Jackson S., Stephen A., et al. Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutr 2009, 101:886-894.
29. Potenza M.A., Marasciulo F.L., Tarquinio M., Tiravanti E., Colantuono G., Federici A., et al. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 2007, 292:1378-1387.
30. Wu L.Y., Juan C.C., Ho L.T., Hsu Y.P., Hwang L.S. Effect of green tea supplementation on insulin sensitivity in Sprague-Dawley rats. J Agric Food Chem 2004, 52:643-648.
31. Cao H., Hininger-Favier I., Kelly M.A., Benaraba R., Dawson H.D., Coves S. Green tea polyphenol extract regulates the expression of genes involved in glucose uptake and insulin signaling in rats fed a high fructose diet. J Agric Food Chem 2007, 55:6372-6378.
32. Zhang Z.F., Li Q., Liang J., Dai X.Q., Ding Y., Wang J.B., et al. Epigallocatechin-3-O-gallate (EGCG) protects the insulin sensitivity in rat L6 muscle cells exposed to dexamethasone condition. Phytomedicine 2010, 17:14-18.
33. Chen N., Bezzina R., Hinch E., Lewandowski P.A., Cameron-Smith D., Mathai M.L., et al. Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet. Nutr Res 2009, 29:784-793.
34. Kotsis V., Stabouli S., Papakatsika S., Rizos Z., Parati G. Mechanisms of obesity-induced hypertension. Hypertens Res 2010, 33:386-393.
35. Kotchen T.A. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens 2010, 23:1170-1178.
36. Montecucco F., Pende A., Quercioli A., Mach F. Inflammation in the pathophysiology of essential hypertension. J Nephrol 2011, 24:23-34.
37. Yang C.S., Lambert J.D., Sang S. Antioxidative and anti-carcinogenic activities of tea polyphenols. Arch Toxicol 2009, 83:11-21.
38. Ahn H.Y., Kim C.H. Epigallocatechin-3-gallate regulates inducible nitric oxide synthase expression in human umbilical vein endothelial cells. Lab Anim Res 2011, 27:85-90.
39. Tayama Y., Sugihara K., Sanoh S., Miyake K., Morita S., Kitamura S., et al. Effect of tea beverages on aldehyde oxidase activity. Drug Metab Pharmacokinet 2011, 26:94-101.
40. Antonello M., Montemurro D., Bolognesi M., Di Pascoli M., Piva A., Grego F., et al. Prevention of hypertension, cardiovascular damage and endothelial dysfunction with green tea extracts. Am J Hypertens 2007, 20:1321-1328.
41. Babu P.V., Liu D. Green tea catechins and cardiovascular health: an update. Curr Med Chem 2008, 15:1840-1850.
42. Takano K., Nakaima K., Nitta M., Shibata F. Inhibitory effect of (-)-epigallocatechin 3-gallate, a polyphenol of green tea, on neutrophil chemotaxis in vitro and in vivo. J Agric Food Chem 2004, 52:4571-4576.
43. AnandhBabu P.V., Sabitha K.E., Shyamaladevi C.S. Green tea extract impedes dyslipidaemia and development of cardiac dysfunction in streptozotocin-diabetic rats. Clin Exp Pharmacol Physiol 2006, 33:1184-1189.
44. Shishikura Y., Khokhar S., Murray B.S. Effects of tea polyphenols on emulsification of olive oil in a small intestine model system. J Agric Food Chem 2006, 54:1906-1913.
45. Wang S., Noh S.K., Koo S.I. Green tea catechins inhibit pancreatic phospholipase A(2) and intestinal absorption of lipids in ovariectomized rats. J Nutr Biochem 2006, 17:492-498.
46. Koo S.I., Noh S.K. Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. J Nutr Biochem 2007, 18:179-183.
47. Stangl V., Lorenz M., Stangl K. The role of tea and tea flavonoids in cardiovascular health. Mol Nutr Food Res 2006, 50:218-228.